Percheron Therapeutics LimitedASX: PER

ATL1102 tox study to support clinical program in the US

Nov 14, 2022 at 3:43 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment